Results 101 to 110 of about 614,692 (233)

Viral hemorrhagic fevers:(Week 5) Weekly cases of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents weeks ending February 02, 2019

This data includes weekly cases of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents, specifically covering Viral hemorrhagic fevers cases.

core  

Human brain matters: Navigating the neuropathology of COVID‐19

Brain Pathology, Volume 36, Issue 6, November 2026.
Severe COVID‐19 is associated with vascular dysregulation and chronic neuroinflammation, leading to axonal injury and neurodegeneration. In long COVID or PASC, persistent alterations in neuroimaging and biofluid biomarkers reflect ongoing neuronal damage and neuroinflammation, contributing to long‐term neurological symptoms including fatigue, cognitive
Juliana M. Nieuwland, Angelica Scaramuzza, Marianna Bugiani, Wilma D. J. van de Berg, Jinte Middeldorp   +4 more
wiley   +1 more source

Viral hemorrhagic fevers:(Week 4) Weekly cases of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents weeks ending January 26, 2019

This data includes weekly cases of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents, specifically covering Viral hemorrhagic fevers cases.

core  

The results of the detection of specific IgG antibodies to Ebola virus (Filoviridae: Orthoebolavirus) in residents of the Republic of Guinea after the end of the epidemic

Вопросы вирусологии
Introduction. In 2014–2016, an epidemic of Ebola virus disease (EVD) was registered in Guinea. In 2021, EVD cases were repeated in the region. The importance of studying the duration of post-infection immunity to the Ebola virus in the body of ...
Ekaterina V. Naidenova, Mikhail Yu. Kartashov, Irina S. Shulgina, Stepan A. Pyankov, Maxim A. Kulagin, Mamadou B. Bah, Ibrahim Nourdine, Magassouba N’Fally, Viktor Konomou, Mohamed S. Traore, Sanaba Boumbaly, Vladimir V. Kutyrev   +11 more
doaj   +1 more source

Feasibility and Safety of Venetoclax for Cytoreduction During Induction Therapy in Newly Diagnosed Acute Promyelocytic Leukemia

European Journal of Haematology, Volume 117, Issue 5, Page 1258-1264, November 2026.
ABSTRACT Objective This study aimed to evaluate the feasibility and safety of venetoclax as a cytoreductive strategy during induction therapy in newly diagnosed acute promyelocytic leukemia (APL), and to provide an exploratory description of its early efficacy.
Yu Wang, Rong Xiao, Xiaobing Huang, Yi Xiao   +3 more
wiley   +1 more source

Viral hemorrhagic fevers (Week 50) Weekly cases of notifiable diseases United States U.S. territories and Non-U.S. Residents weeks ending December 14, 2019

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Viral hemorrhagic fevers cases.

core  

Recombinant Human Thrombopoietin Reduces the Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia

American Journal of Hematology, Volume 101, Issue 10, Page 2571-2580, October 2026.
ABSTRACT Chronic liver disease (CLD)‐related thrombocytopenia can limit the feasibility of invasive procedures. Recombinant human thrombopoietin (rhTPO) has demonstrated a favorable safety profile without hepatotoxicity. We evaluated the efficacy and safety of rhTPO in patients with CLD‐related thrombocytopenia who were undergoing elective invasive ...
Yifan Han, Ning Lin, Jinghang Xu, Sikui Wang, Jinglan Jin, Jia Shang, Yongning Xin, Youwen Tan, Dazhi Zhang, Jinlin Hou, Ping An, Wen Xie, Yujuan Guan, Qingfang Xiong, Hong Wu, Huiguo Ding, Yu Chen, Rongkuan Li, Zhili Wen, Mingqin Lu, Jinhui Yang, Zhongyin Zhou, Yongjian Zhou, Zujiang Yu, Kecan Lin, Wei Wang, Yan Huang, Yuemin Nan, Xinhua Luo, Rongshu Shi, Yi Kang, Tao Han, Shiyan Chen, Kai Wang, Yunfeng Shan, Jiaping Li, Pingguo Liu, Zheng Lu, Jun Chen, Zhen Liu, Liaoyun Zhang, Li Yang, Jifang Sheng, Zhan Zeng, Yanyan Yu, Xiaoyuan Xu   +45 more
wiley   +1 more source

Viral hemorrhagic fevers:(Week 26) Weekly cases of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents weeks ending June 27, 2020

This data includes weekly cases of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents, specifically covering Viral hemorrhagic fevers cases.

core  

The vaccines based on the replicon of the venezuelan equine encephalomyelitis virus against viral hemorrhagic fevers

Вопросы вирусологии, 2015
The status of the various recombinant DNA and RNA-derived candidate vaccines, as well as the Venezuelan equine encephalomyelitis virus (VEEV) replicon vaccine system against extremely hazardous viral hemorrhagic fevers, were reviewed.
A. A. Petrov, T. M. Plekhanova, O. N. Sidorova, S. V. Borisevich, A. A. Makhlay   +4 more
doaj  

Histidine Supplementation Stabilizes Hearing and Vision and Improves Growth in HARS1‐Related Autosomal Recessive Disorder Associated With Usher‐Like Symptoms

American Journal of Medical Genetics Part A, Volume 200, Issue 10, Page 2289-2308, October 2026.
ABSTRACT Autosomal recessive HARS1‐related disorder (originally described as Usher syndrome type 3B) caused by a homozygous Y454S variant in the histidyl‐tRNA synthetase gene (HARS1) is characterized by progressive sensorineural hearing and vision loss and respiratory deterioration with risk for sudden death following febrile illnesses.
Victoria Mok Siu, Rosan Kenana, Rana Chakrabarti, Sarah D. P. Wilhelm, Joseph Andrews, Susan J. Leat, Christina Parker, Michael Miller, Leslie A. Nangle, Wendy McCaul, Ashfia Chowdhury, Natalie Hutchings, Ryan A. Adams, Lauren Guy, Mandy Rhody, Verena Juncal, Marisa I. Mendes, Desiree E. C. Smith, Gajja S. Salomons, Angelica A. Moresco, Daphne L. McCulloch, D. Holmes Morton, Ilka U. Heinemann, C. Anthony Rupar   +23 more
wiley   +1 more source